Pharmaceuticals

Everest Organics Ltd

Showing the latest 10 filings. Sign in to filter or browse the full history.
10 of 35 filings·Updated 17 Aug 2026
Showing 10 of 35 filings.
17 Aug 20261 filing
Company UpdateNewspaper Publication

News Paper publications of Un-audited Financial Results for the Quarter ended June 30, 2026

Filed 11:58View Source
14 Aug 20261 filing
ResultFinancial Results

Everest Organics approves Q1 FY27 unaudited standalone results; audit review qualified on PCB issue

Q1 FY27 highlights

  • Board approved the unaudited standalone results for quarter ended June 30, 2026.
  • Limited Review Report is qualified on Telangana PCB non-compliance matter.
  • Total sales turnover for quarter ended 30 June 2026: Rs 4,843.00 lakhs.
  • Domestic turnover Rs 3,764.83 lakhs; Export turnover Rs 1,078.23 lakhs.
  • Company operates in a single API and intermediates segment.
  • Equity shares in unclaimed suspense account as of 30 June 2026.
  • Auditor's review is not an audit; scope is limited per SRE 2410.
Filed 16:23View Source
6 Aug 20261 filing
Board Meeting

Everest Organics to hold board meeting on Aug 14, 2026 to approve unaudited Q1 results and AGM notices

Meeting Details

  • Board meeting scheduled for Friday, August 14, 2026.

Key Agenda Items

  • Consider and approve the unaudited financial results for the quarter ended June 30, 2026.
  • Consider and note statutory auditors' limited review report on unaudited results for quarter ended June 30, 2026.
  • Consider and approve the Board’s Report with annexures for FY 2025-26.
  • Fix the time, date, and venue of the 33rd AGM and approve its notice for FY 2025-26.
  • Appoint the Scrutinizer for the 33rd AGM.

Other Notes

  • Trading window closed from July 01, 2026 until 48 hours after the unaudited results declaration.
Filed 15:32View Source
11 Jul 20261 filing
Company UpdateAllotment of Equity Shares

The Board of Directors approved by way of Circular Resolution on July 11, 2026, the Allotment of 263157 fully paid-up equity shares of Rs. 10 each at a price of Rs. 152 each upon conversion ....

Filed 12:58View Source
7 Apr 20261 filing
Company UpdateNewspaper Publication

Newspaper publication- Special window for transfer and dematerialization of physical securities.

Filed 11:05View Source
23 Mar 20261 filing
Insider Trading / SASTClosure of Trading Window

Closure of Trading Window

Filed 10:54View Source
6 Mar 20261 filing
Company UpdateGeneral

Disclosure of reason for delay in submission of financial results for the quarter ended December 31, 2025.

Filed 12:19View Source
12 Feb 20261 filing
Company UpdateBoard Meeting Rescheduled

Everest Organics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2026 ,inter alia, to consider and approve i. Un-Audited Financial Results ....

Filed 12:10View Source
22 Jan 20261 filing
Company UpdateGeneral

Report on re-lodgement of transfer request of physical shares.

Filed 14:50View Source
17 Jan 20261 filing
Company UpdateCertificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Certificate under SEBI ( Depositories and Participants) Regulations, 2018.

Filed 09:40View Source
Showing 10 of 35 filings